|
Number
|
No.
|
42
|
4
|
63
|
|
Gender
|
Males
|
10
|
3
|
20
|
|
Females
|
32
|
1
|
43
|
|
Age
|
Mean (range)
|
55 (28–87)
|
55 (40–84)
|
44 (23–78)
|
|
Age at initial diagnosis
|
Mean (range)
|
53 (27–81)
|
51 (38–83)
|
N/A
|
|
Follow-up since initial diagnosis (years)
|
Mean (range)
|
2.6 (0.12–14.7)
|
3.8 (0.5–10.5)
|
N/A
|
|
Grade
|
Grade 1
|
32
|
–
|
N/A
|
|
Grade 2
|
10
|
–
|
|
Grade 3 NET
|
–
|
1
|
|
NEC
|
–
|
3
|
|
Ki-67 (%)
|
Mean (range)
|
2.5 (1–17)
|
51 (30–75)
|
N/A
|
|
Active Chronic Atrophic Gastritis
|
% (N)
|
81% (34)
|
N/A
|
N/A
|
|
Gastrin Levels [N ≤ 115 pg/ml]
|
% Elevated
|
75%a
|
25%b
|
N/A
|
|
Mean FC (range)
|
4.2 (0.12–13.3)
|
0.57 (0.1–1.04)
|
|
Mean Value (range)
|
483 (18–1525)
|
66 (12–120)
|
|
Intestinal Metaplasia
|
No.
|
31
|
0
|
N/A
|
|
Proton pump inhibitor treatment
|
% On treatment
|
7%
|
25%
| |
|
Chromogranin A [N < 100μg/l]
|
% Elevated
|
44%
|
25%
|
N/A
|
|
Mean (range)
|
142 (20–700)
|
203 (20–700)
|
|
Disease extent by imaging and histology
|
Image-positive & R1
|
15
|
1
|
N/A
|
|
Image-negative & R0
|
18
|
3
|
|
Image-negative & R1
|
9
|
–
|
|
Current treatment
|
Type
|
No (Surveillance)
|
No (Surveillance)
|
N/A
|
|
Previous treatments
|
None
|
0
|
1
|
N/A
|
|
Polypectomy
|
24
|
0
|
|
Partial gastrectomy
|
7
|
1
|
|
Total gastrectomy
|
3
|
2
|
